Digital therapeutics formularies five years away in US, say payers

Payers from the US may not include digital therapeutics products on formularies for another five years, according to a report.

Healthcare services firm Icon conducted in-depth interviews with 10 pharmacy and medical directors from health plans and pharmacy benefit managers in the US, to gauge their thoughts on reimbursing digital therapeutics (DTx).